MetLife Price Targets Get Twin Bump from KBW and JPMorgan

MetLife Inc.'s (MET) shares have garnered fresh analyst support as two major research firms raised their price targets on the insurer. Keefe Bruyette & Woods and JPMorgan both revised their targets to $108 per share, up from $105 and $106 respectively.

The price hikes come against a backdrop of steady optimism among analysts. The average rating on MetLife stands at overweight, with a mean price target of $105.20 based on a FactSet poll of analysts.

MetLife's scale across group benefits, retirement solutions, and international markets keeps it on the radar of institutions like KBW and JPMorgan. Analyst upgrades and target increases often reflect updated earnings models or revised assumptions about capital returns.